Is BioCryst Pharmaceuticals, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for BioCryst Pharmaceuticals, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by bearish MACD readings on both weekly and monthly time frames, bearish Bollinger Bands, and a bearish daily moving average. The KST shows a mixed signal with a bearish weekly and bullish monthly, while Dow Theory and OBV both reflect mildly bearish conditions on weekly and monthly bases. Over the past week, the stock has declined by 6.29%, significantly underperforming the S&P 500, which gained 1.09%. Over the past month, the stock is down 13.75% compared to the S&P 500's 4.15% gain, highlighting a persistent underperformance.